Abstract
Obesity is a worldwide health challenge. The clinical consequences of obesity include nonalcoholic fatty liver disease, type 2 diabetes, and coronary heart disease. Numerous diets have been developed to reduce the incidence of cardiovascular diseases and induce weight loss. Low-carbohydrate, high-fat diets (LCHFDs) have become increasingly popular for weight loss. LCHFDs have led to weight loss in some clinical studies. However, the safety of LCHFDs and their long-term effects on the human body are still controversial. In this review, I will discuss the effects of LCHFDs on weight loss, cardiovascular health, and mortality.
In Korea, the prevalence of obesity and abdominal obesity steadily increased from 2009 to 2015.1) In 2015, the prevalence of obesity and abdominal obesity was 32.4% and 20.8%, respectively.1) The clinical consequences of obesity include nonalcoholic fatty liver disease,2) type 2 diabetes,3-5) and coronary heart disease.6) Obesity is associated with increased all-cause mortality.7-9) Numerous diets have been developed to reduce the incidence of cardiovascular diseases and induce weight loss.10) Low-carbohydrate, high-fat diets (LCHFDs) have become increasingly popular for weight loss. LCHFDs have led to weight loss in some clinical studies.11) However, the safety of LCHFDs and their long-term effects on the human body are still controversial. There is concern about the potentially negative effect of these diets on blood lipid levels and the risk of cardiovascular diseases.12) Recent studies that evaluated the effects of LCHFDs on cardiovascular disease risk factors have yielded mixed results, with some studies reporting that LCHFDs have favorable effects on cardiovascular risk factors,13)14) while others reported that LCHFDs have adverse effects in both animals15) and humans.15)16) In this review, we will discuss the effects of LCHFDs on weight loss, cardiovascular health, and mortality.
Despite the controversy surrounding LCHFDs, they are still popular today. One popular LCHFD is Dr. Atkins' Diet Revolution, which was published in 1972.17) Users of LCHFDs experience weight loss during the initial short-term. In a randomized trial, LCHFDs caused a greater weight loss than conventional diets during the first six months; however, the differences were not significant after one year.11) Several randomized trials have shown that low-carbohydrate diets cause a greater short-term (6 months) weight loss than low-fat, calorie-restricted diets.11)14)18-20) The results vary over the long-term (1–2 yeas) trials. Some studies reported greater weight loss when low-carbohydrate diets were used than when low-fat diets were used,14)21) while others found no difference between the two diets.11)22)23) Common limitations of dietary trials include poor adherence and high attrition rates (15–50%).24)25) The restriction of carbohydrate intake reduces total caloric intake. However, in animal studies, the effect of diets on weight change can be investigated in the absence of confounding factors including unequal energy intake. In obese rats, very low-carbohydrate diets decreased body fat loss and insulin sensitivity compared to isocaloric, high-carbohydrate diets.26)27) In one animal study, the high fat group (45%) lost less body weight and adipose depot weight than the low fat group (12%).28) The reason for the weight loss during the initial short-term after using LCHFDs is that the total food intake is reduced due to early satiety.29-31) LCHFDs contain a high proportion of protein. High protein diets induce satiety. Mechanisms that may contribute to high protein diet-induced satiety include an increase in the concentration of ‘satiety’ hormones (Cholecystokinin, PYY, Glucagon-like peptide-1), concentration of amino acids, energy expenditure, and process of gluconeogenesis.31) Insulin activates key enzymes in pathways that derive energy from carbohydrates, and when dietary carbohydrate is low, the resulting decrease in insulin concentration leads to a reduction in lipogenesis and an increase in lipolysis.32) When the intake of LCHFDs is prolonged, the central nervous system is forced to use alternative energy sources.33) This condition leads to the production of ketone bodies (acetoacetate, β-hydroxybutyric acid, and acetone) by the liver.33) LCHFDs are effective for short-term, but not long-term, weight loss. This occurs due to several mechanisms.
The use of LCHFDs is one of the most popular alternative weight loss approaches. LCHFDs have received considerable attention in recent years particularly due to their beneficial effects on cardiovascular risk factors in obese individuals.34) LCHFDs cause a large proportion of energy to be derived from protein and fat, and there is concern about the potentially detrimental effect of these diets on the risk of cardiovascular diseases. Data on the long-term effects of LCHFDs are sparse. In a prospective cohort study, low-carbohydrate diets high in animal sources of fat and protein were associated with higher all-cause and cardiovascular mortality post-myocardial infarction.16) LCHFDs can be high in red meat, low in vegetables, and high in whole grains, which have been shown to increase the risk of chronic diseases.35)36) On the other hand, a low-calorie, low-carbohydrate diet with high amounts of plant protein has been shown to improve low-density lipoprotein (LDL) levels compared to a high-carbohydrate diet.37) Depending on whether the protein and fat are derived from animals or vegetables, the effect on the cardiovascular risk factors may be different. In a meta-analysis of randomized controlled trials, even though low-carbohydrate diets were associated with unfavorable changes in total cholesterol and LDL-cholesterol levels, they were associated with favorable changes in triglyceride and probably high-density lipoprotein (HDL)-cholesterol levels.24) In several studies, LCHFDs reduced glycemic load and risk of type 2 diabetes.38-40) However, a recent study suggested that LCHFDs could even have negative effects on glucose metabolism in healthy men.41) In an animal study, rats fed LCHFDs exhibited insulin resistance and impaired glucose tolerance.42) Garbow et al.43) reported the development of glucose intolerance with no effect on insulin sensitivity in mice fed LCHFDs for 12 weeks. Thus, it remains unclear whether LCHFDs are beneficial for glucose and insulin metabolism in humans and animals. In terms of reducing blood pressure, LCHFD is not superior to the low-fat diet.11)44-46) In animal studies, LCHFDs affect myocardial energy substrate levels and insulin signaling, and increase myocardial injury following ischemia-reperfusion in the isolated heart. Moreover, the impaired recovery of function after ischemia-reperfusion in LCHFDs is due to intrinsic effects of diet on myocardial properties.47)48) In obese rats, LCHFDs cause the derangement of mitochondrial biogenesis and suppress cardiac expression of endogenous antioxidants after myocardial ischemia and reperfusion.49) A recent study suggested that LCHFDs are associated with poor small artery vascular reactivity in patients with increased cardiovascular risk.50) Several animal studies showed favorable effects of LCHFDs on cardiovascular risk. In an animal study, LCHFDs reduced blood pressure and improved arterial function in spontaneously hypertensive rats.51) The effects of LCHFDs on cardiovascular health are inconsistent in several studies. Therefore, currently, LCHFDs are not recommended for the prevention of cardiovascular diseases.
Data on the long-term association between LCHFDs and mortality are sparse. Randomized trials to investigate the effects of LCHFDs on mortality are not feasible because of the difficulty in maintaining compliance and follow-up for several years. In a systematic review and meta-analysis of observational studies, low-carbohydrate diets were associated with a significantly higher risk of all-cause mortality; however, they were not significantly associated with a risk of cardiovascular mortality.52) Low-carbohydrate diets may be linked to an array of chronic health problems. Two studies involving European cohorts reported that a low-carbohydrate, high-protein diet was associated with, a weak but statistically significant, high mortality.53)54) Recently, the association between low-carbohydrate diets and mortality was reported in a study. In the aforementioned prospective cohort study, a low-carbohydrate diet based on animal products was associated with a higher all-cause mortality in both men and women, whereas a vegetable-based low-carbohydrate diet was associated with lower all-cause and cardiovascular disease mortality rates.55) Low-carbohydrate diets may contain variable amounts of plant or animal fat. This may explain why low-carbohydrate diet's effect on lipid profile has a variety of results.24) The association between the intake of red and processed meats and risk of colorectal cancer is well established.56) Additionally, red meat has been associated with higher risk of lung cancer in a prospective study.57)
Even though LCHFDs are more likely to induce a loss of body weight in the short-term than traditional low-fat diets, they have little effect on long-term weight loss or weight maintenance. While there is a clear effect of LCHFDs on triglyceride and HDL cholesterol levels during lipid metabolism, they have no or a negative effect on the total cholesterol and LDL cholesterol levels compared to low-fat diets. The hypoglycemic effect of LCHFDs may be beneficial; however, this has not been confirmed. LCHFD does not affect blood pressure control. LCHFDs have been reported to increase mortality. Therefore, LCHFDs should not be recommended.
REFERENCES
1. Seo MH, Kim YH, Han K, Jung JH, Park YG, Lee SS, Kwon HS, Lee WY, Yoo SJ. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance Service health checkup data 2006-2015. J Obes Metab Syndr. 2018; 27:46–52.
2. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010; 51:679–89.
3. Ni Mhurchu C, Parag V, Nakamura M, Patel A, Rodgers A, Lam TH; Asia Pacific Cohort Studies Collaboration. Body mass index and risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr. 2006; 15:127–33.
4. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol. 2006; 163:1042–52.
5. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010; 89:309–19.
6. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB; Danaei GGlobal Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014; 383:970–83.
7. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010; 363:2211–9.
8. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309:71–82.
9. Davey Smith G, Sterne JA, Fraser A, Tynelius P, Lawlor DA, Rasmussen F. The association between BMI and mortality using offspring BMI as an indicator of own BMI: large intergenerational mortality study. BMJ. 2009; 339:b5043.
10. Parikh P, McDaniel MC, Ashen MD, Miller JI, Sorrentino M, Chan V, Blumenthal RS, Sperling LS. Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol. 2005; 45:1379–87.
11. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003; 348:2082–90.
12. Blackburn GL, Phillips JC, Morreale S. Physician's guide to popular low-carbohydrate weight-loss diets. Cleve Clin J Med. 2001; 68:761. 765-6, 768-9, 773-4.
13. Ruth MR, Port AM, Shah M, Bourland AC, Istfan NW, Nelson KP, Gokce N, Apovian CM. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism. 2013; 62:1779–87.
14. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008; 359:229–41.
15. Muller AP, Dietrich MO; Martimbianco de Assis A, Souza DO, Portela LV. High saturated fat and low carbohydrate diet decreases lifespan independent of body weight in mice. Longev Healthspan. 2013; 2:10.
16. Li S, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Rexrode KM, Mukamal KJ, Rimm EB. Low carbohydrate diet from plant or animal sources and mortality among myocardial infarction survivors. J Am Heart Assoc. 2014; 3:e001169.
17. Atkins RC. r. Atkins' Diet Revolution. Philadelphia, PA: D. McKay Company;1972.
18. Brehm BJ, Seeley RJ, Daniels SR, D’Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003; 88:1617–23.
19. Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a lowfat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004; 140:769–77.
20. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007; 297:969–77.
21. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ, Samaha FF. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med. 2004; 140:778–85.
22. Yancy WS Jr, Westman EC, McDuffie JR, Grambow SC, Jeffreys AS, Bolton J, Chalecki A, Oddone EZ. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010; 170:136–45.
23. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed BS, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med. 2010; 153:147–57.
24. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC. Effects of lowcarbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166:285–93.
25. Malik VS, Hu FB. Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med. 2007; 4:34–41.
26. Axen KV, Axen K. Very low-carbohydrate versus isocaloric high-carbohydrate diet in dietary obese rats. Obesity (Silver Spring). 2006; 14:1344–52.
27. McNeel RL, Mersmann HJ. Low- and high-carbohydrate diets: body composition differences in rats. Obes Res. 2005; 13:1651–60.
28. Cha MC, Johnson JA, Hsu CY, Boozer CN. High-fat hypocaloric diet modifies carbohydrate utilization of obese rats during weight loss. Am J Physiol Endocrinol Metab. 2001; 280:E797–803.
29. Westerterp-Plantenga MS, Nieuwenhuizen A, Tomé D, Soenen S, Westerterp KR. Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr. 2009; 29:21–41.
30. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr. 2013; 67:759–64.
31. Veldhorst M, Smeets A, Soenen S, Hochstenbach-Waelen A, Hursel R, Diepvens K, Lejeune M, LuscombeMarsh N, Westerterp-Plantenga M. Protein-induced satiety: effects and mechanisms of different proteins. Physiol Behav. 2008; 94:300–7.
33. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids. 2004; 70:243–51.
34. Santos FL, Esteves SS, da Costa Pereira A, Yancy WS Jr, Nunes JP. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev. 2012; 13:1048–66.
35. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, Rodriguez C, Sinha R, Calle EE. Meat consumption and risk of colorectal cancer. JAMA. 2005; 293:172–82.
36. Benetou V, Orfanos P, Lagiou P, Trichopoulos D, Boffetta P, Trichopoulou A. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev. 2008; 17:387–92.
37. Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Greaves KA, Paul G, Singer W. The effect of a plant-based low-carbohydrate (“Eco-Atkins”) diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med. 2009; 169:1046–54.
38. Farrés J, Pujol A, Coma M, Ruiz JL, Naval J, Mas JM, Molins A, Fondevila J, Aloy P. Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate lowfat ketogenic diet. Nutr Metab (Lond). 2010; 7:88.
39. Hussain TA, Mathew TC, Dashti AA, Asfar S, Al-Zaid N, Dashti HM. Effect of low-calorie versus lowcarbohydrate ketogenic diet in type 2 diabetes. Nutrition. 2012; 28:1016–21.
40. Westman EC, Vernon MC. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design. Nutr Metab (Lond). 2008; 5:10.
41. Numao S, Kawano H, Endo N, Yamada Y, Konishi M, Takahashi M, Sakamoto S. Short-term low carbohydrate/high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men. Eur J Clin Nutr. 2012; 66:926–31.
42. Bielohuby M, Sisley S, Sandoval D, Herbach N, Zengin A, Fischereder M, Menhofer D, Stoehr BJ, Stemmer K, Wanke R, Tschöp MH, Seeley RJ, Bidlingmaier M. Impaired glucose tolerance in rats fed lowcarbohydrate, high-fat diets. Am J Physiol Endocrinol Metab. 2013; 305:E1059–70.
43. Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, Ezenwajiaku N, Cotter DG, Brunt EM, Crawford PA. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol. 2011; 300:G956–67.
44. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003; 348:2074–81.
45. Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008; 87:567–76.
46. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009; 360:859–73.
47. Wang P, Tate JM, Lloyd SG. Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia. Life Sci. 2008; 83:836–44.
48. Liu J, Wang P, Douglas SL, Tate JM, Sham S, Lloyd SG. Impact of high-fat, low-carbohydrate diet on myocardial substrate oxidation, insulin sensitivity, and cardiac function after ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2016; 311:H1–10.
49. Liu J, Lloyd SG. High-fat, low-carbohydrate diet alters myocardial oxidative stress and impairs recovery of cardiac function after ischemia and reperfusion in obese rats. Nutr Res. 2013; 33:311–21.
50. Merino J, Kones R, Ferré R, Plana N, Girona J, Aragonés G, Ibarretxe D, Heras M, Masana L. Negative effect of a low-carbohydrate, high-protein, high-fat diet on small peripheral artery reactivity in patients with increased cardiovascular risk. Br J Nutr. 2013; 109:1241–7.
51. Bosse JD, Lin HY, Sloan C, Zhang QJ, Abel ED, Pereira TJ, Dolinsky VW, Symons JD, Jalili T. A lowcarbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance. Am J Physiol Heart Circ Physiol. 2013; 304:H1733–42.
52. Noto H, Goto A, Tsujimoto T, Noda M. Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies. PLoS One. 2013; 8:e55030.
53. Lagiou P, Sandin S, Weiderpass E, Lagiou A, Mucci L, Trichopoulos D, Adami HO. Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med. 2007; 261:366–74.
54. Trichopoulou A, Psaltopoulou T, Orfanos P, Hsieh CC, Trichopoulos D. Low-carbohydrate-high-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr. 2007; 61:575–81.
55. Fung TT, van Dam RM, Hankinson SE, Stampfer M, Willett WC, Hu FB. Low-carbohydrate diets and allcause and cause-specific mortality: two cohort studies. Ann Intern Med. 2010; 153:289–98.